RDMD, a Bay Area startup leveraging personal health records to accelerate clinical research of rare diseases, has raised $3 million in seed funding. Support for the company was led by Lux Capital, with participation from Village Global, First Round’s Healthcare Co-Op, Garuda, Shasta Ventures, and other unnamed angel investors.
According to the announcement, the new funding will be directed toward...
In a first for the University of Pennsylvania Health System, Penn Medicine launched a new ResearchKit app today aimed at people with a rare condition called sarcoidosis, which is characterized by inflammation to one or multiple parts of the body including eyes, skin, lungs, heart, brain and other organs.
Called simply Sarcoidosis, the app combines patient resources with research, providing people...
